Murphy DL - Search Results

1

A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder.

Pigott TA, Pato MT, L'Heureux F, Hill JL, Grover GN, Bernstein SE, Murphy DL. Pigott TA, et al. Among authors: murphy dl. J Clin Psychopharmacol. 1991 Aug;11(4):242-8. J Clin Psychopharmacol. 1991. PMID: 1918422 Clinical Trial.

2

Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.

Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL. Zohar J, et al. Among authors: murphy dl. Arch Gen Psychiatry. 1988 Feb;45(2):167-72. doi: 10.1001/archpsyc.1988.01800260081011. Arch Gen Psychiatry. 1988. PMID: 3276283 Clinical Trial.

3

CSF somatostatin in obsessive-compulsive disorder.

Altemus M, Pigott T, L'Heureux F, Davis CL, Rubinow DR, Murphy DL, Gold PW. Altemus M, et al. Among authors: murphy dl. Am J Psychiatry. 1993 Mar;150(3):460-4. doi: 10.1176/ajp.150.3.460. Am J Psychiatry. 1993. PMID: 8094599

4

A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP.

Pigott TA, Hill JL, Grady TA, L'Heureux F, Bernstein S, Rubenstein CS, Murphy DL. Pigott TA, et al. Among authors: murphy dl. Biol Psychiatry. 1993 Jan 1;33(1):3-14. doi: 10.1016/0006-3223(93)90272-f. Biol Psychiatry. 1993. PMID: 8420593 Clinical Trial.

5

Lack of evidence for Huntington's disease-like cognitive dysfunction in obsessive-compulsive disorder.

Martin A, Pigott TA, Lalonde FM, Dalton I, Dubbert B, Murphy DL. Martin A, et al. Among authors: murphy dl. Biol Psychiatry. 1993 Mar 1;33(5):345-53. doi: 10.1016/0006-3223(93)90323-6. Biol Psychiatry. 1993. PMID: 8471692 Review.

6

Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioral and biological results.

Broocks A, Pigott TA, Hill JL, Canter S, Grady TA, L'Heureux F, Murphy DL. Broocks A, et al. Among authors: murphy dl. Psychiatry Res. 1998 Jun 2;79(1):11-20. doi: 10.1016/s0165-1781(98)00029-8. Psychiatry Res. 1998. PMID: 9676822 Clinical Trial.

7

Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.

Murphy DL, Zohar J, Benkelfat C, Pato MT, Pigott TA, Insel TR. Murphy DL, et al. Br J Psychiatry Suppl. 1989 Dec;(8):15-24. Br J Psychiatry Suppl. 1989. PMID: 2692636 Review.

8

Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action.

Benkelfat C, Murphy DL, Zohar J, Hill JL, Grover G, Insel TR. Benkelfat C, et al. Among authors: murphy dl. Arch Gen Psychiatry. 1989 Jan;46(1):23-8. doi: 10.1001/archpsyc.1989.01810010025004. Arch Gen Psychiatry. 1989. PMID: 2910220 Clinical Trial.

9

Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.

Pato MT, Zohar-Kadouch R, Zohar J, Murphy DL. Pato MT, et al. Among authors: murphy dl. Am J Psychiatry. 1988 Dec;145(12):1521-5. doi: 10.1176/ajp.145.12.1521. Am J Psychiatry. 1988. PMID: 3057923 Clinical Trial.

10

Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.

Pigott TA, Zohar J, Hill JL, Bernstein SE, Grover GN, Zohar-Kadouch RC, Murphy DL. Pigott TA, et al. Among authors: murphy dl. Biol Psychiatry. 1991 Mar 1;29(5):418-26. doi: 10.1016/0006-3223(91)90264-m. Biol Psychiatry. 1991. PMID: 2018816 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

893 results

Search Page

Filters